Journal
HEPATIC ONCOLOGY
Volume 4, Issue 1, Pages 15-24Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/hep-2016-0010
Keywords
bridging therapy; down-staging therapy; extended criteria; hepatocellular carcinoma; immunosuppressant; liver transplantation; Milan Criteria; salvage transplantation
Categories
Ask authors/readers for more resources
Orthotopic liver transplantation (LT) has been regarded as the best cure among the three curative treatment modalities. However, when to consider LT in hepatocellular carcinoma (HCC) patients remains a complicated clinical question. In this article, we will look into the recent updates in the context of LT for HCC, including the timing of orthotopic LT (primary or salvage LT), patient selection criteria, newer prognostic markers and scoring systems, downstaging and bridging therapy, salvage LT and treatment option of post-LT HCC recurrence. Evolution of immunosuppressive therapy and future development of the LT for HCC will also be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available